Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy
dc.contributor.author | Willemse, Peter-Paul M. | |
dc.contributor.author | Davis, Niall F. | |
dc.contributor.author | Grivas, Nikolaos | |
dc.contributor.author | Zattoni, Fabio | |
dc.contributor.author | Lardas, Michael | |
dc.contributor.author | Briers, Erik | |
dc.contributor.author | Cumberbatch, Marcus G. | |
dc.contributor.author | De Santis, Maria | |
dc.contributor.author | Dell'Oglio, Paolo | |
dc.contributor.author | Donaldson, James F. | |
dc.contributor.author | Fossati, Nicola | |
dc.contributor.author | Gandaglia, Giorgio | |
dc.contributor.author | Gillessen, Silke | |
dc.contributor.author | Grummet, Jeremy P. | |
dc.contributor.author | Henry, Ann M. | |
dc.contributor.author | Liew, Matthew | |
dc.contributor.author | MacLennan, Steven | |
dc.contributor.author | Mason, Malcolm D. | |
dc.contributor.author | Moris, Lisa | |
dc.contributor.author | Plass, Karin | |
dc.contributor.author | O'Hanlon, Shane | |
dc.contributor.author | Omar, Muhammad Imran | |
dc.contributor.author | Oprea-Lager, Daniela E. | |
dc.contributor.author | Pang, Karl H. | |
dc.contributor.author | Paterson, Catherine | |
dc.contributor.author | Ploussard, Guillaume | |
dc.contributor.author | Rouvière, Olivier | |
dc.contributor.author | Schoots, Ivo G. | |
dc.contributor.author | Tilki, Derya | |
dc.contributor.author | van den Bergh, Roderick C.N. | |
dc.contributor.author | van den Broeck, Thomas | |
dc.contributor.author | van der Kwast, Theodorus H. | |
dc.contributor.author | van der Poel, Henk G. | |
dc.contributor.author | Wiegel, Thomas | |
dc.contributor.author | Yuan, Cathy Yuhong | |
dc.contributor.author | Cornford, Philip | |
dc.contributor.author | Mottet, Nicolas | |
dc.contributor.author | Lam, Thomas B.L. | |
dc.date.accessioned | 2022-12-02T00:11:18Z | |
dc.date.available | 2022-12-02T00:11:18Z | |
dc.date.issued | 2022-04-01 | |
dc.identifier.citation | Willemse , P-P M , Davis , N F , Grivas , N , Zattoni , F , Lardas , M , Briers , E , Cumberbatch , M G , De Santis , M , Dell'Oglio , P , Donaldson , J F , Fossati , N , Gandaglia , G , Gillessen , S , Grummet , J P , Henry , A M , Liew , M , MacLennan , S , Mason , M D , Moris , L , Plass , K , O'Hanlon , S , Omar , M I , Oprea-Lager , D E , Pang , K H , Paterson , C , Ploussard , G , Rouvière , O , Schoots , I G , Tilki , D , van den Bergh , R C N , van den Broeck , T , van der Kwast , T H , van der Poel , H G , Wiegel , T , Yuan , C Y , Cornford , P , Mottet , N & Lam , T B L 2022 , ' Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy ' , European Urology , vol. 81 , no. 4 , pp. 337-346 . https://doi.org/10.1016/j.eururo.2021.12.007 | en |
dc.identifier.issn | 0302-2838 | |
dc.identifier.other | PURE: 209713415 | |
dc.identifier.other | PURE UUID: 7c4710b2-b8cd-4ab8-b5e0-9ac889bc6c25 | |
dc.identifier.other | ORCID: /0000-0002-2691-8421/work/110638014 | |
dc.identifier.other | ORCID: /0000-0002-1597-3126/work/110638144 | |
dc.identifier.other | Scopus: 85122352845 | |
dc.identifier.uri | https://hdl.handle.net/2164/19666 | |
dc.format.extent | 10 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Urology | en |
dc.rights | © 2021. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Systematic review | en |
dc.subject | active surveillance | en |
dc.subject | localized prostate cancer | en |
dc.subject | consensus statements | en |
dc.subject | criteria for inclusion and eligibility | en |
dc.subject | monitoring and reclassification | en |
dc.subject | positive cores | en |
dc.subject | core involvement | en |
dc.subject | per-protocol or untriggered repeat biopsies | en |
dc.subject | clinical practice guidelines and recommendations | en |
dc.subject | R Medicine | en |
dc.subject | Supplementary Data | en |
dc.subject.lcc | R | en |
dc.title | Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1016/j.eururo.2021.12.007 | |
dc.identifier.vol | 81 | en |
dc.identifier.iss | 4 | en |